Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$3.4 - $4.24 $38,209 - $47,649
-11,238 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$3.76 - $5.14 $42,254 - $57,763
11,238 New
11,238 $47,000
Q1 2021

May 10, 2021

SELL
$4.81 - $8.74 $54,208 - $98,499
-11,270 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$5.03 - $6.31 $56,688 - $71,113
11,270 New
11,270 $59,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $104M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.